Treatments: Once-Weekly Exenatide LAR Clinical Study In Type 2 ...
Posted on Thu, 04 Dec 2008 16:03:38 -0800 in Diabetes teeth (Category: Default)
Amylin, Lilly, and Alkermes are working reciprocally to change a continual giving out, subcutaneous immunisation of exenatide for the of type 2 diabetes produce by Alkermes' proprietary Medisorb® technology. ...
Tags: alkermes treatment type exenatide technology